Press Release Archive
Press Releases
October 2022
10.05.2022
Financial Investments Pfizer Completes Acquisition of Global Blood Therapeutics
10.04.2022
10.04.2022
Research and Pipeline Research Pfizer Announces Positive Topline Results from Phase 3 TALAPRO-2 Trial
10.03.2022
Financial Finance Investments Pfizer Completes Acquisition of Biohaven Pharmaceuticals
September 2022
09.26.2022
09.22.2022
Financial Finance Pfizer Declares Fourth-Quarter 2022 Dividend
09.22.2022
Prescription Medicines Medicines Pfizer to Supply Global Fund Up to 6 Million PAXLOVID™ Treatment Courses for Low-and-Middle-Income Countries
09.20.2022
09.20.2022
09.19.2022
Research and Pipeline Research Vaccines Pfizer Announces Positive Top-Line Results from Phase 3 Study in 20-Valent Pneumococcal Conjugate Vaccine in Infants in the European Union
09.15.2022
09.14.2022
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.